Registration Programme Overview Exhibition Virtual Exhibition Satellite Programme Hotel Information VISA Letter Application

 

Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

ICL removal due to cataract formation combined with phacoemulsification and toric PCIOL implantation: a case report

Poster Details


First Author: V.Peponis GREECE

Co Author(s): A. Makris   E. Paroikakis   A. Afrati   L. Kontomihos   V. Konstantinidou        

Abstract Details

Purpose:

Our purpose is to present a case of an ICL removal because of underlying anterior subcapsular cataract formation in a 54 year old male patient who presented in our clinic. His visual acuity OD was CF in 1m, OS was pseudophakic with a UCVA of 20/30. The treatment plan chosen was the removal of the ICL followed by phacoemulsification and toric PCIOL implantation OD.

Setting:

Opthalmiatrion of Athens, Athens, Greece.

Methods:

Standard optical biometry (Carl Zeiss Meditec IOLMaster®) was used and standard IOL power calculation formulas were implemented (HofferQ and SRK/T). We opted for a toric PCIOL implantation (Alcon,AcrySof® Toric IOL, SN6T8) with a power of +32D 5.25cyl to address the patient's hyperopia and astigmatism. Stellaris phacoemulsification machine was used (Bausch + Lomb). Intraoperatively a video of the surgery was recorded.

Results:

The surgical procedure was uneventful. On post-op visit day 1 no significant inflammation or infection was noted, the cornea had no edema. On post-op visit day 30 the refraction showed a SE of -0.75D which was within the pre-op target. The UCVA OD was 20/20 with good patient satisfaction.

Conclusions:

In our case standard biometry and IOL calculation in the eye with the ICL needed to be removed resulted in no refractive surprise. There was no need to modify the surgical technique of the phacoemulsification after the removal of the ICL. There were no problems with the IOL power calculation preoperatively and there were no intra-or post-operative complications. Patient satisfaction was good.

Financial Disclosure:

None

Back to Poster listing